Rennova Health, Inc. (RNVA)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2022 | 15.32 Million USD | -4.54% |
| 2021 | 16.05 Million USD | -27.08% |
| 2020 | 22.02 Million USD | -56.31% |
| 2019 | 50.4 Million USD | 135.3% |
| 2018 | 21.42 Million USD | 37.91% |
| 2017 | 15.53 Million USD | 20.32% |
| 2016 | 12.9 Million USD | 7.36% |
| 2015 | 12.02 Million USD | 2262.42% |
| 2014 | 509 Thousand USD | -87.7% |
| 2013 | 4.13 Million USD | 720.91% |
| 2012 | 504 Thousand USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | -100.0% |
| 2007 | 14 Thousand USD | 40.0% |
| 2006 | 10 Thousand USD | -65.52% |
| 2005 | 29 Thousand USD | -83.14% |
| 2004 | 172 Thousand USD | -93.5% |
| 2003 | 2.64 Million USD | 521.6% |
| 2002 | 426 Thousand USD | -53.8% |
| 2001 | 922 Thousand USD | -76.26% |
| 2000 | 3.88 Million USD | 45.58% |
| 1999 | 2.66 Million USD | 1234.0% |
| 1998 | 200 Thousand USD | -50.0% |
| 1997 | 400 Thousand USD | -33.33% |
| 1996 | 600 Thousand USD | -75.0% |
| 1995 | 2.4 Million USD | -81.1% |
| 1994 | 12.7 Million USD | 63.66% |
| 1993 | 7.76 Million USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 Q2 | 12.45 Million USD | -9.96% |
| 2023 Q1 | 13.83 Million USD | -9.77% |
| 2023 Q3 | 12.23 Million USD | -1.75% |
| 2022 Q2 | 15.16 Million USD | -2.22% |
| 2022 Q1 | 15.51 Million USD | -3.4% |
| 2022 Q4 | 15.32 Million USD | 0.66% |
| 2022 Q3 | 15.22 Million USD | 0.4% |
| 2022 FY | 15.32 Million USD | -4.54% |
| 2021 Q2 | 23.67 Million USD | 1.87% |
| 2021 Q4 | 16.05 Million USD | -31.57% |
| 2021 FY | 16.05 Million USD | -27.08% |
| 2021 Q1 | 23.23 Million USD | 5.51% |
| 2021 Q3 | 23.46 Million USD | -0.86% |
| 2020 Q2 | 36.59 Million USD | -32.28% |
| 2020 Q1 | 54.02 Million USD | 7.19% |
| 2020 Q3 | 21.89 Million USD | -40.16% |
| 2020 Q4 | 22.02 Million USD | 0.57% |
| 2020 FY | 22.02 Million USD | -56.31% |
| 2019 Q2 | 33.68 Million USD | 24.58% |
| 2019 Q1 | 27.04 Million USD | 26.23% |
| 2019 FY | 50.4 Million USD | 135.3% |
| 2019 Q4 | 50.4 Million USD | 4.55% |
| 2019 Q3 | 48.21 Million USD | 43.12% |
| 2018 Q4 | 21.42 Million USD | 14.76% |
| 2018 FY | 21.42 Million USD | 37.91% |
| 2018 Q2 | 19.79 Million USD | 16.55% |
| 2018 Q1 | 16.98 Million USD | 9.33% |
| 2018 Q3 | 18.66 Million USD | -5.69% |
| 2017 Q2 | 15.07 Million USD | 41.89% |
| 2017 Q1 | 10.62 Million USD | -17.68% |
| 2017 FY | 15.53 Million USD | 20.32% |
| 2017 Q4 | 15.53 Million USD | 11.04% |
| 2017 Q3 | 13.98 Million USD | -7.23% |
| 2016 Q3 | 12.63 Million USD | -23.99% |
| 2016 Q1 | 15.73 Million USD | 47.06% |
| 2016 Q2 | 16.62 Million USD | 5.63% |
| 2016 FY | 12.9 Million USD | 7.36% |
| 2016 Q4 | 12.9 Million USD | 2.18% |
| 2015 Q3 | 337 Thousand USD | -37.71% |
| 2015 FY | 12.02 Million USD | 2262.42% |
| 2015 Q2 | 541 Thousand USD | 1.5% |
| 2015 Q1 | 533 Thousand USD | 1.52% |
| 2015 Q4 | 10.7 Million USD | 3075.37% |
| 2014 Q4 | 525 Thousand USD | 1.55% |
| 2014 FY | 509 Thousand USD | -87.7% |
| 2014 Q1 | 509 Thousand USD | 0.2% |
| 2014 Q3 | 517 Thousand USD | 1.17% |
| 2014 Q2 | 511 Thousand USD | 0.39% |
| 2013 Q4 | 508 Thousand USD | 0.2% |
| 2013 Q3 | 507 Thousand USD | 0.4% |
| 2013 Q2 | 505 Thousand USD | 0.2% |
| 2013 Q1 | 504 Thousand USD | 0.8% |
| 2013 FY | 4.13 Million USD | 720.91% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q3 | 500 Thousand USD | 0.0% |
| 2012 Q4 | 500 Thousand USD | 0.0% |
| 2012 FY | 504 Thousand USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2009 Q1 | - USD | -100.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 Q4 | 1000.00 USD | -83.33% |
| 2008 Q2 | 8000.00 USD | -42.86% |
| 2008 Q1 | 14 Thousand USD | 0.0% |
| 2008 Q3 | 6000.00 USD | -25.0% |
| 2008 FY | - USD | -100.0% |
| 2007 FY | 14 Thousand USD | 40.0% |
| 2007 Q1 | 10 Thousand USD | -72.97% |
| 2007 Q2 | - USD | -100.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2006 Q3 | 25 Thousand USD | -76.64% |
| 2006 Q1 | 29 Thousand USD | -19.44% |
| 2006 FY | 10 Thousand USD | -65.52% |
| 2006 Q2 | 107 Thousand USD | 268.97% |
| 2006 Q4 | 37 Thousand USD | 48.0% |
| 2005 Q2 | 96 Thousand USD | -44.19% |
| 2005 Q4 | 36 Thousand USD | -32.08% |
| 2005 Q1 | 172 Thousand USD | -84.89% |
| 2005 FY | 29 Thousand USD | -83.14% |
| 2005 Q3 | 53 Thousand USD | -44.79% |
| 2004 Q4 | 1.13 Million USD | 7.77% |
| 2004 Q2 | 305 Thousand USD | -88.48% |
| 2004 FY | 172 Thousand USD | -93.5% |
| 2004 Q1 | 2.64 Million USD | 806.85% |
| 2004 Q3 | 1.05 Million USD | 246.23% |
| 2003 Q1 | 426 Thousand USD | -11.62% |
| 2003 Q3 | 191 Thousand USD | -73.58% |
| 2003 FY | 2.64 Million USD | 521.6% |
| 2003 Q4 | 292 Thousand USD | 52.88% |
| 2003 Q2 | 723 Thousand USD | 69.72% |
| 2002 Q4 | 482 Thousand USD | -66.29% |
| 2002 Q1 | 922 Thousand USD | -35.34% |
| 2002 Q2 | 570 Thousand USD | -38.18% |
| 2002 FY | 426 Thousand USD | -53.8% |
| 2002 Q3 | 1.43 Million USD | 150.88% |
| 2001 Q4 | 1.42 Million USD | -54.59% |
| 2001 Q1 | 3.88 Million USD | -8.76% |
| 2001 Q2 | 5.39 Million USD | 38.9% |
| 2001 FY | 922 Thousand USD | -76.26% |
| 2001 Q3 | 3.14 Million USD | -41.8% |
| 2000 FY | 3.88 Million USD | 45.58% |
| 2000 Q3 | 5.64 Million USD | 35.37% |
| 2000 Q4 | 4.25 Million USD | -24.59% |
| 2000 Q2 | 4.17 Million USD | 56.3% |
| 2000 Q1 | 2.66 Million USD | -64.89% |
| 1999 FY | 2.66 Million USD | 1234.0% |
| 1999 Q2 | 900 Thousand USD | 350.0% |
| 1999 Q3 | 3.5 Million USD | 288.89% |
| 1999 Q4 | 7.6 Million USD | 117.14% |
| 1999 Q1 | 200 Thousand USD | -71.43% |
| 1998 Q2 | 700 Thousand USD | 75.0% |
| 1998 Q4 | 700 Thousand USD | 16.67% |
| 1998 FY | 200 Thousand USD | -50.0% |
| 1998 Q1 | 400 Thousand USD | -55.56% |
| 1998 Q3 | 600 Thousand USD | -14.29% |
| 1997 FY | 400 Thousand USD | -33.33% |
| 1997 Q4 | 900 Thousand USD | -70.97% |
| 1997 Q1 | 600 Thousand USD | -40.0% |
| 1997 Q3 | 3.1 Million USD | 10.71% |
| 1997 Q2 | 2.8 Million USD | 366.67% |
| 1996 Q3 | 4.1 Million USD | -12.77% |
| 1996 Q4 | 1 Million USD | -75.61% |
| 1996 FY | 600 Thousand USD | -75.0% |
| 1996 Q1 | 2.4 Million USD | -31.43% |
| 1996 Q2 | 4.7 Million USD | 95.83% |
| 1995 Q4 | 3.5 Million USD | -79.25% |
| 1995 FY | 2.4 Million USD | -81.1% |
| 1995 Q3 | 16.87 Million USD | 17.4% |
| 1995 Q1 | 12.7 Million USD | 0.0% |
| 1995 Q2 | 14.37 Million USD | 13.15% |
| 1994 FY | 12.7 Million USD | 63.66% |
| 1993 FY | 7.76 Million USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| American Bio Medica Corporation | 2.24 Million USD | -584.346% |
| Arrayit Corporation | 1.07 Million USD | -1321.797% |
| Atlantic International Corp. | 2.93 Million USD | -423.099% |
| Biocept, Inc. | 12.1 Million USD | -26.595% |
| Bioqual, Inc. | 3.58 Million USD | -327.36% |
| CardioGenics Holdings Inc | 72.61 Thousand USD | -21010.732% |
| DermTech, Inc. | 54.39 Million USD | 71.818% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 471.86 Million USD | 96.751% |
| HTG Molecular Diagnostics, Inc. | 4.83 Million USD | -217.119% |
| iMD Companies, Inc. | 1.12 Million USD | -1268.51% |
| IDenta Corp. | 789.14 Thousand USD | -1842.524% |
| Interpace Biosciences, Inc. | 11.19 Million USD | -36.967% |
| Integrative Health Technologies, Inc. | - USD | -Infinity% |
| InVitro International | 43.84 Thousand USD | -34862.589% |
| Lumos Diagnostics Holdings Limited | 8.04 Million USD | -90.547% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 3.82 Million USD | -300.674% |
| NovelStem International Corp. | 3.57 Million USD | -328.841% |
| Optigenex Inc. | 8.94 Million USD | -71.455% |
| PharmChem, Inc. | 77.35 Thousand USD | -19717.392% |
| Proteome Sciences plc | 17.15 Million USD | 10.635% |
| Response Genetics, Inc | 6.37 Million USD | -140.536% |
| RushNet, Inc. | 4.82 Million USD | -217.832% |
| ScreenPro Security Inc. | 207.03 Thousand USD | -7304.265% |
| Stella Diagnostics Inc. | 6.2 Million USD | -147.22% |
| StageZero Life Sciences Ltd. | 1.8 Million USD | -751.591% |
| Todos Medical Ltd. | 38.34 Million USD | 60.026% |